A scientific journey through the 2-5A/RNase L system

被引:80
作者
Silverman, Robert H. [1 ]
机构
[1] Cleveland Clin, Dept Canc Biol, Cleveland, OH 44195 USA
关键词
2-5A; RNase L; interferon; cancer; virus;
D O I
10.1016/j.cytogfr.2007.06.012
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The antiviral and antitumor actions of interferons are caused, in part, by a remarkable regulated RNA cleavage pathway known as the 2-5A/RNase L system. 2 '-5 ' linked oligoadenylates (2-5A) are produced from ATP by interferon-inducible synthetases. 2-5A activates pre-existing RNase L, resulting in the cleavage of RNAs within single-stranded regions. Activation of RNase L by 2-5A leads to an antiviral response, although precisely how this happens is a subject of ongoing investigations. Recently, RNase L was identified as the hereditary prostate cancer 1 gene. That finding has led to the discovery of a novel human retrovirus, XMRV. My scientific journey through the 2-5A system recounts some of the highlights of these efforts. Knowledge gained from studies on the 2-5A system could have an impact on development of therapies for important viral pathogens and cancer. (c) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:381 / 388
页数:8
相关论文
共 106 条
[1]  
ANDERSEN JB, 2006, ROLE 25 DEPENDENT RN
[2]   INTERFERON ACTION MAY BE MEDIATED BY ACTIVATION OF A NUCLEASE BY PPPA2'P5'A2'P5'A [J].
BAGLIONI, C ;
MINKS, MA ;
MARONEY, PA .
NATURE, 1978, 273 (5664) :684-687
[3]   CLONING AND CHARACTERIZATION OF A RNASE-L INHIBITOR - A NEW COMPONENT OF THE INTERFERON-REGULATED 2-5A PATHWAY [J].
BISBAL, C ;
MARTINAND, C ;
SILHOL, M ;
LEBLEU, B ;
SALEHZADA, T .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (22) :13308-13317
[4]   Germline mutations in the ribonuclease L gene in families showing linkage with HPC1 [J].
Carpten, J ;
Nupponen, N ;
Isaacs, S ;
Sood, R ;
Robbins, C ;
Xu, J ;
Faruque, M ;
Moses, T ;
Ewing, C ;
Gillanders, E ;
Hu, P ;
Buinovszky, P ;
Makalowska, I ;
Baffoe-Bonnie, A ;
Faith, D ;
Smith, J ;
Stephan, D ;
Wiley, K ;
Brownstein, M ;
Gildea, D ;
Kelly, B ;
Jenkins, R ;
Hostetter, G ;
Matikainen, M ;
Schleutker, J ;
Klinger, K ;
Connors, T ;
Xiang, Y ;
Wang, Z ;
De Marzo, A ;
Papadopoulos, N ;
Kallioniemi, OP ;
Burk, R ;
Meyers, D ;
Grönberg, H ;
Meltzer, P ;
Silverman, R ;
Bailey-Wilson, J ;
Walsh, P ;
Isaacs, W ;
Trent, J .
NATURE GENETICS, 2002, 30 (02) :181-184
[5]  
Carroll SS, 1996, J BIOL CHEM, V271, P4988
[6]   Activation of RNase L by 2',5'-oligoadenylates - Kinetic characterization [J].
Carroll, SS ;
Cole, JL ;
Viscount, T ;
Geib, J ;
Gehman, J ;
Kuo, LC .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (31) :19193-19198
[7]   RNASEL Arg462Gln variant is implicated in up to 13% of prostate cancer cases [J].
Casey, G ;
Neville, PJ ;
Plummer, SJ ;
Xiang, Y ;
Krumroy, LM ;
Klein, EA ;
Catalona, WJ ;
Nupponen, N ;
Carpten, JD ;
Trent, JM ;
Silverman, RH ;
Witte, JS .
NATURE GENETICS, 2002, 32 (04) :582-583
[8]   A study of the interferon antiviral mechanism: Apoptosis activation by the 2-5A system [J].
Castelli, JC ;
Hassel, BA ;
Wood, KA ;
Li, XL ;
Amemiya, K ;
Dalakas, MC ;
Torrence, PF ;
Youle, RJ .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (06) :967-972
[9]   The role of 2′-5′ oligoadenylate-activated ribonuclease L in apoptosis [J].
Castelli, JC ;
Hassel, BA ;
Maran, A ;
Paranjape, J ;
Hewitt, JA ;
Li, XL ;
Hsu, YT ;
Silverman, RH ;
Youle, RJ .
CELL DEATH AND DIFFERENTIATION, 1998, 5 (04) :313-320
[10]   VIRUS-MEDIATED INHIBITION OF THE PPP(A2'P) A SYSTEM AND ITS PREVENTION BY INTERFERON-N [J].
CAYLEY, PJ ;
KNIGHT, M ;
KERR, IM .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 104 (02) :376-382